Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Sales, net	$ 9,770	$ 12,681
Cost of sales	8,765	10,529
Gross profit	1,005	2,152
Selling and administrative expenses	794	793
Operating income	211	1,359
Other income (expense), net:
Interest expense	(233)	(232)
Change in fair value of derivative liabilities	(118)	(368)
Impairment on investment in iBio, Inc.	(83)
Other income, net		16
Total other expense, net	(434)	(584)
(Loss) income before income taxes	(223)	775
Income tax (benefit) expense, net	(44)	126
Net (loss) income	$ (179)	$ 649
Basic net (loss) income per common share (in dollars per share)	$ (0.01)	$ 0.03
Diluted net (loss) income per common share (in dollars per share)	$ (0.01)	$ 0.03
Weighted average common shares outstanding - basic (in shares)	21,135,174	21,105,174
Add: Equivalent shares outstanding (in shares)		77,712
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)
Weighted average common shares outstanding - diluted (in shares)	21,135,174	21,182,886